Literature DB >> 30366106

SLAMF6 in health and disease: Implications for therapeutic targeting.

Burcu Yigit1, Ninghai Wang2, Roland W Herzog3, Cox Terhorst4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30366106      PMCID： PMC8969216          DOI： 10.1016/j.clim.2018.10.013

Source DB:  PubMed          Journal:  Clin Immunol        ISSN： 1521-6616            Impact factor:   3.969


× No keyword cloud information.
  290 in total

1.  Germinal center T follicular helper cell IL-4 production is dependent on signaling lymphocytic activation molecule receptor (CD150).

Authors:  Isharat Yusuf; Robin Kageyama; Laurel Monticelli; Robert J Johnston; Daniel Ditoro; Kyle Hansen; Burton Barnett; Shane Crotty
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

2.  CD84 mediates CLL-microenvironment interactions.

Authors:  A Marom; A F Barak; M P Kramer; H Lewinsky; I Binsky-Ehrenreich; S Cohen; A Tsitsou-Kampeli; V Kalchenko; Y Kuznetsov; V Mirkin; N Dezorella; M Shapiro; P L Schwartzberg; Y Cohen; L Shvidel; M Haran; S Becker-Herman; Y Herishanu; I Shachar
Journal:  Oncogene       Date:  2016-07-25       Impact factor: 9.867

3.  The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and activates the PI3K and phospholipase Cgamma signaling pathways in human NK cells.

Authors:  Ilaria Tassi; Marco Colonna
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

4.  Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.

Authors:  S K Kumar; J H Lee; J J Lahuerta; G Morgan; P G Richardson; J Crowley; J Haessler; J Feather; A Hoering; P Moreau; X LeLeu; C Hulin; S K Klein; P Sonneveld; D Siegel; J Bladé; H Goldschmidt; S Jagannath; J S Miguel; R Orlowski; A Palumbo; O Sezer; S V Rajkumar; B G M Durie
Journal:  Leukemia       Date:  2011-07-29       Impact factor: 11.528

5.  Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia.

Authors:  S Kitada; J M Zapata; M Andreeff; J C Reed
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

6.  Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer.

Authors:  Alan G Ramsay; Andrew J Clear; Rewas Fatah; John G Gribben
Journal:  Blood       Date:  2012-04-30       Impact factor: 22.113

7.  Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses.

Authors:  Marta Cuenca; Xavier Romero; Jordi Sintes; Cox Terhorst; Pablo Engel
Journal:  J Immunol       Date:  2015-12-14       Impact factor: 5.422

8.  T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.

Authors:  John C Riches; Jeffrey K Davies; Fabienne McClanahan; Rewas Fatah; Sameena Iqbal; Samir Agrawal; Alan G Ramsay; John G Gribben
Journal:  Blood       Date:  2012-12-17       Impact factor: 22.113

9.  SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors.

Authors:  Jaime De Calisto; Ninghai Wang; Guoxing Wang; Burcu Yigit; Pablo Engel; Cox Terhorst
Journal:  Front Immunol       Date:  2014-04-23       Impact factor: 7.561

10.  The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.

Authors:  Inna Gordiienko; Larysa Shlapatska; Valeriia Kholodniuk; Lilia Sklyarenko; Daniel F Gluzman; Edward A Clark; Svetlana P Sidorenko
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240
View more
  6 in total

1.  Urinary Cell Transcriptome Profiling and Identification of ITM2A, SLAMF6, and IKZF3 as Biomarkers of Acute Rejection in Human Kidney Allografts.

Authors:  Bryan J Dooley; Akanksha Verma; Ruchuang Ding; Hua Yang; Thangamani Muthukumar; Michele Lubetzky; Divya Shankaranarayanan; Olivier Elemento; Manikkam Suthanthiran
Journal:  Transplant Direct       Date:  2020-07-22

2.  SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function.

Authors:  Marianne Strazza; Kieran Adam; Shalom Lerrer; Johanna Straube; Sabina Sandigursky; Beatrix Ueberheide; Adam Mor
Journal:  Inflammation       Date:  2021-02-24       Impact factor: 4.657

3.  SLAMF6 clustering is required to augment T cell activation.

Authors:  Matthew A Dragovich; Kieran Adam; Marianne Strazza; Anna S Tocheva; Michael Peled; Adam Mor
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

4.  N6-Methyladenosine-Related Gene Signature Associated With Monocyte Infiltration Is Clinically Significant in Gestational Diabetes Mellitus.

Authors:  Runyu Du; Ling Li; Yanjun Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-18       Impact factor: 5.555

5.  Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes.

Authors:  Konstantin Byrgazov; Thomas Lind; Annica J Rasmusson; Claes Andersson; Ana Slipicevic; Fredrik Lehmann; Joachim Gullbo; Håkan Melhus; Rolf Larsson; Mårten Fryknäs
Journal:  Bone Rep       Date:  2021-06-07

6.  Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis.

Authors:  Ye-Hui Chen; Shao-Hao Chen; Jian Hou; Zhi-Bin Ke; Yu-Peng Wu; Ting-Ting Lin; Yong Wei; Xue-Yi Xue; Qing-Shui Zheng; Jin-Bei Huang; Ning Xu
Journal:  Aging (Albany NY)       Date:  2019-10-31       Impact factor: 5.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.